Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
ProQR Therapeutics N.V.
Sort By
Newest First
Sign in
1 / 1
1 / 1
FDA
ProQR Receives Rare Pediatric Disease Designation from FDA for QR-421a
ProQR Therapeutics
PR-M01-20-NI-044
Jan 30, 2020
Ophthalmology
Tackling Genetic Eye Diseases with Novel RNA Therapies
Daniel A. de Boer
ProQR Therapeutics
PAP-Q4-19-CL-027
Dec 06, 2019
